3SBIO INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.86 HKD | +4.26% |
|
+19.72% | -8.78% |
| 22/04 | 3Sbio Inc. Announces Management Changes | CI |
| 15/04 | 3SBIO Gets China Nod for Use of Cancer Injection in Children with Thrombocytopenia | MT |
Chart calendar 3SBio Inc.
116e53b47b.iUNNMz9ldXjwCqZW-YaGLeTjE3XLnjZtwI-Mx4o3_JU.2iIHR2AuNiGgQsElse_ZRZOtfhearlAuosq_9PtiuubGcgRhZg4iCsJE0Q~5da6e06aaebe48d0ab72529f4f84e9e3
Upcoming events on 3SBio Inc.
Past events on 3SBio Inc.
| 20/03/2024 | Q4 2023 Earnings Release |
| 25/08/2023 07:24 am | Q2 2023 Earnings Release |
| 20/06/2023 07:30 am | Annual General Meeting |
| 22/03/2023 08:26 am | Q4 2022 Earnings Release |
| 24/08/2022 | Interim 2022 Earnings Release |
| 28/03/2022 | FY 2021 Earnings Release |
| 26/08/2021 07:00 am | Interim 2021 Earnings Call |
| 25/08/2021 04:29 pm | Interim 2021 Earnings Release |
| 30/03/2021 | FY 2020 Earnings Release |
| 17/08/2020 | Interim 2020 Earnings Release |
| 19/06/2020 08:30 am | Annual General Meeting |
| 30/03/2020 | FY 2019 Earnings Release |
| 06/11/2019 | Credit Suisse China Investment Conference |
| 09/09/2019 | Morgan Stanley Global Health Care Conference |
| 20/06/2019 07:30 am | Annual General Meeting |
| 20/03/2019 | FY 2018 Earnings Call |
| 20/03/2019 | FY 2018 Earnings Release |
| 10/01/2019 06:30 am | J.P. Morgan Healthcare Conference |
| 20/08/2018 | Interim 2018 Earnings Release |
| 20/06/2018 | Annual General Meeting |
Past dividends on 3SBio Inc.
| 27/06/2023 | Annual 0.1 HKD |
| 27/06/2022 | Annual 0.2 HKD |
| 29/06/2018 | Annual 0.0685 HKD |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 4 584 4 674 -1.92% | 5 318 5 545 -4.1% | 5 588 5 811 -3.85% | 6 382 6 421 -0.61% | 6 859 6 734 1.87% | 7 816 7 791 0.32% |
|
EBITDA Million CNY | Released Forecast Spread | 1 782 1 697 5.03% | 2 005 1 907 5.14% | 1 606 2 002 -19.77% | 2 190 2 109 3.87% | 2 796 2 197 27.25% | 2 768 2 718 1.85% |
|
EBIT Million CNY | Released Forecast Spread | 1 212 1 397 -13.21% | 1 652 1 474 12.06% | 1 503 1 674 -10.22% | 1 642 1 703 -3.55% | 1 658 1 898 -12.65% | 1 915 2 399 -20.16% |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 1 496 1 359 10.04% | 1 223 1 490 -17.89% | 979 1 630 -39.95% | 1 869 1 748 6.93% | 2 274 2 080 9.35% | 1 978 2 417 -18.14% |
|
Net income Million CNY | Released Forecast Spread | 1 277 1 147 11.38% | 974 1 234 -21.08% | 836 1 357 -38.41% | 1 651 1 460 13.09% | 1 915 1 752 9.32% | 1 549 2 041 -24.08% |
|
EPS CNY | Released Forecast Spread | 0,49 0,44 10.63% | 0,38 0,47 -19.24% | 0,33 0,53 -37.65% | 0,62 0,56 11.38% | 0,74 0,68 8.27% | 0,62 0,82 -24% |
| Announcement Date | 20/03/19 | 30/03/20 | 30/03/21 | 28/03/22 | 21/03/23 | 20/03/24 |
Quarterly results
| Fiscal Period | December | 2019 S1 | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 2 643 2 778 -4.87% | 2 675 2 898 -7.68% | 2 695 2 688 0.28% | 2 892 3 354 -13.77% | 3 110 3 163 -1.69% | 3 275 3 525 -7.09% | 3 091 3 474 -11% | 3 768 3 867 -2.57% | 3 784 3 572 5.93% | 4 032 4 148 -2.8% | 4 352 | 4 631 | 4 498 | 5 254 |
|
EBIT Million CNY | Released Forecast Spread | 915 761 20.22% | 727 778 -6.5% | 802 931 -13.82% | 856 1 206 -29.03% | 1 301 1 015 28.12% | 615 1 101 -44.18% | 1 427 | 1 312 | 1 496 | 1 494 | ||||
|
EPS CNY | Released Forecast Spread | 0,13 0,24 -45.83% | 0,25 0,29 -13.79% | 0,27 0,23 17.39% | 0,06 0,26 -76.92% | 0,34 0,32 6.25% | 0,28 0,25 12% | 0,37 0,30 23.33% | 0,37 0,34 8.82% | 0,39 0,35 11.43% | 0,23 0,40 -42.5% | 0,44 | 0,39 | 0,45 | 0,44 |
| Announcement Date | 21/08/19 | 30/03/20 | 17/08/20 | 30/03/21 | 25/08/21 | 28/03/22 | 24/08/22 | 21/03/23 | 24/08/23 | 20/03/24 | - | - | - | - |
| 06/05/2024 04:30 pm | AXSOME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | BIOTEST AG: Q1 2024 Earnings Release |
| 07/05/2024 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | APELLIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 11:30 am | BIOGAIA AB: Q1 2024 Earnings Release |
| 07/05/2024 05:00 pm | INTRA-CELLULAR THERAPIES, INC.: Q1 2024 Earnings Release |
| 08/05/2024 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 08/05/2024 | ZAI LAB LIMITED: Q1 2024 Earnings Release |
| 08/05/2024 05:25 pm | VERICEL CORPORATION: Q1 2024 Earnings Release |
| 09/05/2024 | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
Past sector events for 3SBio Inc.
| 03/05/2024 01:35 am | TWIST BIOSCIENCE CORPORATION: Q2 2024 Earnings Release |
| 02/05/2024 05:20 pm | ARBUTUS BIOPHARMA CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 05:00 pm | BRIDGEBIO PHARMA, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | SK BIOSCIENCE CO.,LTD.: Q1 2024 Earnings Release |
| 30/04/2024 04:30 pm | INCYTE CORPORATION: Q1 2024 Earnings Release |
| 30/04/2024 | SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q4 2023 Earnings Release |
| 30/04/2024 | SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q1 2024 Earnings Release |
| 30/04/2024 | BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: Q4 2023 Earnings Release |
| 30/04/2024 03:23 am | SINOVAC BIOTECH LTD.: Q4 2023 Earnings Release |
| 29/04/2024 | SHANGHAI OPM BIOSCIENCES CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 1530 Stock
- Calendar 3SBio Inc.
